MVM Life Science Partners is a leading Venture Capital firm that invests in technologies and products for the life science and healthcare markets. MVM has teams in London and Boston.

Read more about MVM

11th August 2008
Cortria Appoints Dr. Gene Cefali as SVP Clinical Pharmacology & Formulation Development
Cortria Corporation announces the appointment of Gene Cefali, Pharm.D., Ph.D., a globally recognised niacin metabolism and pharmacokinetics expert, as Senior Vice President of Clinical Pharmacology and Formulation Development.
Read this article

14th July 2008
Cortria Announces Appointment of CEO & Director
Domain Associates & MVM today announced the appointment of Daniel Grau as CEO & Vice-Chairman and Richard King as Director of Cortria.
Read this article